[Infliximab-induced lupus erythematosus in a case of ulcerative colitis].

Nishikawa, Jun; Miyazaki, Takako; Suzuki, Nobuhiro; Itaya, Yuko; Yamawaki, Hidemoto; Mihara, Hiroshi; Hasumoto, Yushi; Fujinami, Haruka; Ogawa, Kohei; Hosokawa, Ayumu; Kudo, Takahiko; Sugiyama, Toshiro

Nishikawa, Jun; Miyazaki, Takako; Suzuki, Nobuhiro; Itaya, Yuko; Yamawaki, Hidemoto; Mihara, Hiroshi; Hasumoto, Yushi; Fujinami, Haruka; Ogawa, Kohei; Hosokawa, Ayumu; Kudo, Takahiko; Sugiyama, Toshiro.

Afiliación

Nishikawa J; Department of Gastroenterology and Hematology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.

Nihon Shokakibyo Gakkai Zasshi ; 108(9): 1535-9, 2011 Sep.

Article en Ja | MEDLINE | ID: mdl-21891993

Asunto(s)

Antiinflamatorios/efectos adversos; Anticuerpos Monoclonales/efectos adversos; Colitis Ulcerosa/tratamiento farmacológico; Lupus Eritematoso Sistémico/inducido químicamente; Adulto; Femenino; Humanos; Infliximab

Buscar en Google

Imprimir

XML

PubMed Links

Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Lupus Eritematoso Sistémico / Antiinflamatorios / Anticuerpos Monoclonales Tipo de estudio: Screening_studies Idioma: Ja Revista: Nihon Shokakibyo Gakkai Zasshi Año: 2011 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links